The Greater New York Autism Research Center of Excellence, a collaborative effort of the Mount Sinai School of Medicine, New York State Psychiatric Institute/Research Foundation for Mental Hygiene, University of Toronto, State University of New York at Stony Brook, and North Shore-Long-Island Jewish Health System, will aim to better understand the functions of the serotonin system in autism, specifically in its relation to repetitive behaviors, by combining methodologies from genetics, functional imaging and neuropsychopharmacology. By investigating core symptom domains of autism and linking this information to etiological factors, the multidisciplinary center's basic science and clinical research will facilitate development of novel or improved strategies for diagnosis, early detection and treatment of autism spectrum disorders. In achieving these goals, the center will be comprised of four integrated cores that will facilitate three interrelated research projects as well as multi-center collaborative endeavors. Project I: Identification of Autism Susceptibility Genes; Project II: Imaging Serotonin Function in Asperger's Disorder; Project Ill: Fluoxetine versus Placebo in Child/Adolescent Autistic Disorder. Core B: Clinical Core; Core C: Data Management and Statistics Core; Core D: Information Transfer Core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54MH066673-03
Application #
6931974
Study Section
Special Emphasis Panel (ZRG1-BBBP-6 (50))
Program Officer
Oliveri, Mary Ellen
Project Start
2003-05-13
Project End
2008-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
3
Fiscal Year
2005
Total Cost
$1,646,312
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Psychiatry
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Zhu, Zuobin; Lu, Xitong; Yuan, Dejian et al. (2017) Close genetic relationships between a spousal pair with autism-affected children and high minor allele content in cases in autism-associated SNPs. Genomics 109:9-15
Correia, Catarina; Oliveira, Guiomar; Vicente, Astrid M (2014) Protein interaction networks reveal novel autism risk genes within GWAS statistical noise. PLoS One 9:e112399
Gaugler, Trent; Klei, Lambertus; Sanders, Stephan J et al. (2014) Most genetic risk for autism resides with common variation. Nat Genet 46:881-5
King, Bryan H; Dukes, Kimberly; Donnelly, Craig L et al. (2013) Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. JAMA Pediatr 167:1045-52
Hallett, Victoria; Lecavalier, Luc; Sukhodolsky, Denis G et al. (2013) Exploring the manifestations of anxiety in children with autism spectrum disorders. J Autism Dev Disord 43:2341-52
Casey, Jillian P; Magalhaes, Tiago; Conroy, Judith M et al. (2012) A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet 131:565-79
Scahill, Lawrence; McCracken, James T; Bearss, Karen et al. (2012) Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders. J Autism Dev Disord 42:432-40
Anney, Richard; Klei, Lambertus; Pinto, Dalila et al. (2012) Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum Mol Genet 21:4781-92
Hollander, Eric; Soorya, Latha; Chaplin, William et al. (2012) A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry 169:292-9
Vavolizza, Rick D; Schmeidler, James; Ramoz, Nicolas et al. (2012) The effect of an autism-associated polymorphism in the STK39 gene on the autism symptom domains. J Autism Dev Disord 42:319-20

Showing the most recent 10 out of 47 publications